Biotest
Natali Eckl is a skilled Prozessmanagerin at Biotest AG since October 2023, following a significant tenure at Exyte from September 2018 to September 2023, where roles included Lead Engineer Process and Projektingenieur. Prior experience includes an internship at Novartis in 2017 and an internship at Vetter Pharma from March to November 2016. Natali holds a Master of Science in Biochemical Engineering from the University of Birmingham, earned between 2017 and 2018, and a Bachelor of Science in Pharmaceutical Biotechnology from Fachhochschule Biberach, completed in 2017.
This person is not in the org chart
This person is not in any teams
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.